{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:56:13Z","timestamp":1792252573133,"version":"4.4.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,8,15]]},"DOI":"10.2169\/internalmedicine.4554-20","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T22:06:23Z","timestamp":1597442783000},"page":"1977-1981","source":"Crossref","is-referenced-by-count":9,"title":["Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist"],"prefix":"10.2169","volume":"59","author":[{"given":"Sho","family":"Hayashida","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Tsuzura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Amano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayato","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Nagahara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Juntendo University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Genda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Kaijser R. Zur Kenntnis der allergischen Affektionen des Verdauungskanals vom Standpunkt des Chirurgen aus. Arch Klin Chir 188: 36-64, 1937."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mansoor E, Saleh MA, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017. Clin Gastroenterol Hepatol 15: 1733-1741, 2017.","DOI":"10.1016\/j.cgh.2017.05.050"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kinoshita Y, Furuta K, Ishimaura N, et al. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol 48: 333-339, 2013.","DOI":"10.1007\/s00535-012-0640-x"},{"key":"4","unstructured":"4. Zhang M, Li Y. Eosinophilic gastroenteritis: a state-of-the-art review. J Gastroenterol Hepatol 32: 64-72, 2017."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Matsuoka K, Kobayashi T, Ueno F, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol 53: 305-353, 2018.","DOI":"10.1007\/s00535-018-1439-1"},{"key":"6","unstructured":"6. eHealthMe [Internet]. [cited 2020 Jan 18]. Available from: https:\/\/www.ehealthme.com\/"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8. Boura P, Sarantopoulos A, Lefaki I, et al. Eosinophilic cellulitis (Wells&apos; syndrome) as a cutaneous reaction to the administration of adalimumab. Ann Rheum Dis 65: 839-840, 2006.","DOI":"10.1136\/ard.2005.044685"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Vester K, R\u00fcger RD, Harth W, Simon JC. Transient blood eosinophilia during treatment with adalimumab. J Eur Acad Dermatol Venereol 26: 924-925, 2012.","DOI":"10.1111\/j.1468-3083.2011.04169.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10. Muir A, Surrey L, Kriegermeier A, Shaikhkalil A, Piccoli DA. Severe eosinophilic gastroenteritis in a Crohn&apos;s disease patient treated with infliximab and adalimumab. Am J Gastroenterol 111: 437-438, 2016.","DOI":"10.1038\/ajg.2015.438"},{"key":"10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000334805","volume":"223","author":"B Malisiewicz","year":"2011","unstructured":"11. Malisiewicz B, Murer C, Pachlopnik Schmid J, et al. Eosinophilia during psoriasis treatment with TNF antagonists. Dermatology 223: 311-315, 2011.","journal-title":"Dermatology","ISSN":"https:\/\/id.crossref.org\/issn\/1018-8665","issn-type":"print"},{"key":"11","doi-asserted-by":"publisher","unstructured":"12. Kobayashi T, Okamoto S, Hisamatsu T, et al. IL23 differentially regulates the Th1\/Th17 balance in ulcerative colitis and Crohn&apos;s disease. Gut 57: 1682-1689, 2008.","DOI":"10.1136\/gut.2007.135053"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13. Mattes J, Foster PS. Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin. Curr Drug Targets Inflamm Allergy 2: 169-174, 2003.","DOI":"10.2174\/1568010033484214"},{"key":"13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000441668","volume":"93","author":"Y Kinoshita","year":"2016","unstructured":"14. Kinoshita Y, Ishimura N, Oshima N, et al. Recent progress in the research of eosinophilic esophagitis and gastroenteritis. Digestion 93: 7-12, 2016.","journal-title":"Digestion","ISSN":"https:\/\/id.crossref.org\/issn\/0012-2823","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Tugnet N, Youssef A, Whallett AJ. Wells&apos; syndrome (eosinophilic cellulitis) secondary to infliximab. Rheumatology (Oxford) 51: 195-196, 2012.","DOI":"10.1093\/rheumatology\/ker322"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Boura P, Sarantopoulos A, Lefaki I, Skendros P, Papadopoulos P. Eosinophilic cellulitis (Wells&apos; syndrome) as a cutaneous reaction to the administration of adalimumab. Ann Rheum Dis 65: 839-840, 2006.","DOI":"10.1136\/ard.2005.044685"},{"key":"16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000330330","volume":"223","author":"P Quaglino","year":"2011","unstructured":"17. Quaglino P, Bergallo M, Ponti R, et al. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology 223: 57-67, 2011.","journal-title":"Dermatology","ISSN":"https:\/\/id.crossref.org\/issn\/1018-8665","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18. Klein NC, Hargrove RL, Sleisenger MH, Jeffries GH. Eosinophilic gastroenteritis. Medicine (Baltimore) 49: 299-319, 1970.","DOI":"10.1097\/00005792-197007000-00003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Khan S. Eosinophilic gastroenteritis. Best Pract Res Clin Gastroenterol 19: 177-198, 2005.","DOI":"10.1016\/j.bpg.2005.01.009"},{"key":"19","unstructured":"20. Sunkara T, Rawla P, Yarlagadda KS, Gaduputi V. Eosinophilic gastroenteritis: diagnosis and clinical perspectives. Clin Exp Gastroenterol 12: 239-253, 2019."},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Walker MM, Potter M, Talley NJ. Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus. Lancet Gastroenterol Hepatol 3: 271-280, 2018.","DOI":"10.1016\/S2468-1253(18)30005-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Reed C, Woosley JT, Dellon ES. Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis. Dig Liver Dis 47: 197-201, 2015.","DOI":"10.1016\/j.dld.2014.11.009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Sandborn WJ, Su C, Sands BE, et al. Tofacitinib as induction and maintenance therapy for ulcerative colitis. N Engl J Med 376: 1723-1736, 2017.","DOI":"10.1056\/NEJMoa1606910"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/16\/59_4554-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T03:11:42Z","timestamp":1597461102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/16\/59_4554-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,15]]},"references-count":22,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4554-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,15]]}}}